The structure and dynamics of GPCR oligomers: A new focus in models of cell-signaling mechanisms and drug design

Current Opinion in Drug Discovery and Development

Volumn 8, Issue 5, 2005, Pages 577-584

  Filizola, Marta ^a   Weinstein, Harel ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Dimerization; GPCRs; Molecular modeling; Oligomerization

Indexed keywords

G PROTEIN COUPLED RECEPTOR;

DIMERIZATION; DRUG DESIGN; DRUG RESEARCH; LIGAND BINDING; MOLECULAR MODEL; OLIGOMERIZATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; DRUG DESIGN; HUMANS; LIGANDS; MODELS, MOLECULAR; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 24044480644     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Brink CB, Harvey BH, Bodenstein J, Venter DP, Oliver DW: Recent advances in drug action and therapeutics: Relevance of novel concepts in G protein-coupled receptor and signal transduction pharmacology. Br J Clin Pharmacol (2004) 57(4):373-387.
2. George SR, O'Dowd BF, Lee SP: G protein-coupled receptor oligomerization and its potential for drug discovery. Nat Rev Drug Discov (2002) 1(10):808-820. Provides a comprehensive and interesting review directly addressing the rationale for the suggested implication of GPCR oligomerization in drug discovery processes.
3. Terrillon S, Bouvier M: Roles of G protein-coupled receptor dimerization. EMBO Rep (2004) 5(1):30-34.
4. Javitch JA: The ants go marching two by two: Oligomeric structure of G protein-coupled receptors. Mol Pharmacol (2004) 66(5):1077-1082.
5. Milligan G: G protein-coupled receptor dimerization: Function and ligand pharmacology. Mol Pharmacol (2004) 66(1):1-7.
6. Bai M: Dimerization of G protein-coupled receptors: Roles in signal transduction. Cell Signal (2004) 16(2):175-186.
7. Park PS, Filipek S, Wells JW, Palczewski K: Oligomerization of G protein-coupled receptors: Past, present and future. Biochemistry (2004) 43(50):15643-15656.
8. Hamm HE: How activated receptors couple to G proteins. Proc Natl Acad Sci USA (2001) 98(9):4819-4821.
9. Filipek S, Krzysko KA, Fotiadis D, Liang Y, Saperstein DA, Engel A, Palczewski K: A concept for G protein activation by G protein-coupled receptor dimers: The transducin/rhodopsin interface. Photochem Photobiol Sci (2004) 3(6):628-638.
10. Liang Y, Fotiadis D, Filipek S, Saperstein DA, Palczewski K, Engel A: Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J Biol Chem (2003) 278(24):21655-21662. Reports the first semi-empirical model of a higher order structure of rhodopsin in native membranes, based on inferences from an atomic force microscopy map. Specifically, this model interprets the experimental data to reflect the organization of rhodopsin molecules into two-dimensional arrays of dimers with their transmembrane helices TM4 and TM5 engaged in intradimeric contact.
11. Fotiadis D, Liang Y, Filipek S, Saperstein DA, Engel A, Palczewski K: Atomic force microscopy: Rhodopsin dimers in native disc membranes. Nature (2003) 421(6919):127-128.
12. Teller DC, Okada T, Behnke CA, Palczewski K, Stenkamp RE: Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G protein-coupled receptors (GPCRs). Biochemistry (2001) 40(26):7761-7772.
13. Filipek S: Organization of rhodopsin molecules in native membranes of rod cells - an old theoretical model compared to new experimental data. J Mol Model (2005): epublished ahead of print.
14. Sondek J, Bohm A, Lambright DG, Hamm HE, Sigler PB: Crystal structure of a G protein β γ dimer at 2.1 Å resolution. Nature (1996) 379(6563):369-374.
15. Lambright DG, Sondek J, Bohm A, Skiba NP, Hamm HE, Sigler PB: The 2.0 Å crystal structure of a heterotrimeric G protein. Nature (1996) 379(6563):311-319.
16. 4 receptor BLT1 and the G protein. J Mol Biol (2003) 329(4):815-829. Results from this research are of outstanding interest, as they provide for the first time direct evidence for a 2:1 stoichiometry between a GPCR dimer and a heterotrimeric G protein, suggesting a novel pentameric assembly.
17. Chabre M, le Maire M: Monomeric G protein-coupled receptor as a functional unit. Biochemistry (2005) 44(27):9395-9403.
18. Pin JP, Kniazeff J, Liu J, Binet V, Goudet C, Rondard P, Prezeau L: Allosteric functioning of dimeric class C G protein-coupled receptors. FEBS J (2005) 272(12):2947-2955.
19. Pin JP, Galvez T, Prezeau L: Evolution, structure and activation mechanism of family 3/C G protein-coupled receptors. Pharmacol Ther (2003) 98(3):325-354.
20. Kunishima N, Shimada Y, Tsuji Y, Sato T, Yamamoto M, Kumasaka T, Nakanishi S, Jingami H, Morikawa K: Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature (2000) 407(6807):971-977.
21. Tsuji Y, Shimada Y, Takeshita T, Kajimura N, Nomura S, Sekiyama N, Otomo J, Usukura J, Nakanishi S, Jingami H: Cryptic dimer interface and domain organization of the extracellular region of metabotropic glutamate receptor subtype 1. J Biol Chem (2000) 275(36):28144-28151.
22. B2 subunit. J Biol Chem (2004) 279(16):15824-15830.
23. B G protein-coupled receptor in its active state. J Neurosci (2004) 24(2):370-377.
24. Bessis AS, Rondard P, Gaven F, Brabet I, Triballeau N, Prezeau L, Acher F, Pin JP: Closure of the Venus flytrap module of mGlu8 receptor and the activation process: Insights from mutations converting antagonists into agonists. Proc Natl Acad Sci USA (2002) 99(17):11097-11102.
25. 3+. Proc Natl Acad Sci USA (2002) 99(5):2660-2665.
26. Tateyama M, Abe H, Nakata H, Saito O, Kubo Y: Ligand-induced rearrangement of the dimeric metabotropic glutamate receptor 1α Nat Struct Mol Biol (2004) 11(7):637-642.
27. Kniazeff J, Bessis AS, Maurel D, Ansanay H, Prezeau L, Pin JP: Closed state of both binding domains of homodimeric mGlu receptors is required for full activity. Nat Struct Mol Biol (2004) 11(8):706-713.
28. Goudet C, Kniazeff J, Hlavackova V, Malhaire F, Maurel D, Acher F, Blahos J, Prezeau L, Pin JP: Asymmetric functioning of dimeric metabotropic glutamate receptors disclosed by positive allosteric modulators. J Biol Chem (2005): epublished ahead of print.
29. Hlavackova V, Goudet C, Kniazeff J, Zikova A, Maurel D, Vol C, Trojanova J, Prezeau L, Pin JP, Blahos J: Evidence for a single heptahelical domain being turned on upon activation of a dimeric GPCR. EMBO J (2005) 24(3):499-509. Reports experimental data that are consistent with a model in which a single monomer of a GPCR homodimeric receptor is switched on upon activation. Important issues are raised in deciphering the functional role of GPCR dimer formation for G protein activation.
30. B receptor function. EMBO J (2001) 20(9):2152-2159.
31. B receptor. J Biol Chem (2002) 277(5):3236-3241.
32. B receptor. Proc Natl Acad Sci USA (2001) 98(25):14643-14648.
33. Jastrzebska B, Maeda T, Zhu L, Fotiadis D, Filipek S, Engel A, Stenkamp RE, Palczewski K: Functional characterization of rhodopsin monomers and dimers in detergents. J Biol Chem (2004) 279(52):54663-54675.
34. Chinault SL, Overton MC, Blumer KJ: Subunits of a yeast oligomeric G protein-coupled receptor are activated independently by agonist but function in concert to activate G protein heterotrimers. J Biol Chem (2004) 279(16):16091-16100.
35. 4 receptor BLT1. J Biol Chem (2004) 279(48):49664-49670. Reports experimental data that provide a direct demonstration of cooperative agonist-induced conformational changes in a GPCR dimer. The inference is based on differences in the affinity for an agonist between the wild-type and a mutant protomer in this dimer, which only exists in the unliganded state. Specifically, variations in the fluorescence emission of a 5-hydroxytryptophan residue in the unliganded mutant protomer suggest that agonist binding to the wild-type protomer induces conformational changes in the unliganded receptor.
36. Percherancier Y, Berchiche YA, Slight I, Volkmer-Engert R, Tamamura H, Fujii N, Bouvier M, Heveker N: Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers. J Biol Chem (2005) 280(11):9895-9903. Presents experimental data that support a model in which GPCR homo- and heterodimers form spontaneously and respond to ligand binding as units that undergo conformational changes involving both protomers, even when only one of the two ligand binding sites is occupied.
37. Ayoub MA, Levoye A, Delagrange P, Jockers R: Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers. Mol Pharmacol (2004) 66(2):312-321.
38. Rocheville M, Lange DC, Kumar U, Sasi R, Patel RC, Patel YC: Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. J Biol Chem (2000) 275(11):7862-7869.
39. 2 vasopressin receptors determines the interaction with β-arrestin and their trafficking patterns. Proc Natl Acad Sci USA (2004) 101(6):1548-1553.
40. Carrillo JJ, Pediani J, Milligan G: Dimers of class A G protein-coupled receptors function via agonist-mediated transactivation of associated G proteins. J Biol Chem (2003) 278(43):42578-42587.
41. Lee C, Ji I, Ryu K, Song Y, Conn PM, Ji TH: Two defective heterozygous luteinizing hormone receptors can rescue hormone action. J Biol Chem (2002) 277(18):15795-15800.
42. Spiegel AM, Weinstein LS: Inherited diseases involving G proteins and G protein-coupled receptors. Annu Rev Med (2004) 55:27-39.
43. Maggio R, Novi F, Scarselli M, Corsini GU: The impact of G protein-coupled receptor hetero-oligomerization on function and pharmacology. FEBS J (2005) 272(12):2939-2946.
44. Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, Devi LA: A role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia. Proc Natl Acad Sci USA (2004) 101(14):5135-5139. Presents an experimental study demonstrating the existence of functional heteromers of δ- and μ-opioid receptors in vivo that may explain the effect of δ-opioid receptor ligands in modulating μ-receptor-mediated analgesia.
45. Waldhoer M, Fong J, Jones RM, Lunzer MM, Sharma SK, Kostenis E, Portoghese PS, Whistler JL: From the cover: A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers. Proc Natl Acad Sci USA (2005) 102(25):9050-9055.
46. Jordan BA, Cvejic S, Devi LA: Opioids and their complicated receptor complexes. Neuropsychopharmacology (2000) 23(4 Suppl):S5-S18.
47. Jordan BA, Devi LA: G protein-coupled receptor heterodimerization modulates receptor function. Nature (1999) 399(6737):697-700.
48. Devi LA: Heterodimerization of G protein-coupled receptors: Pharmacology, signaling and trafficking. Trends Pharmacol Sci (2001) 22(10):532-537.
49. Pan YX, Bolan E, Pasternak GW: Dimerization of morphine and orphanin FQ/nociceptin receptors: Generation of a novel opioid receptor subtype. Biochem Biophys Res Commun (2002) 297(3):659-663.
50. George SR, Fan T, Xie Z, Tse R, Tam V, Varghese G, O'Dowd BF: Oligomerization of μ- and δ-opioid receptors. Generation of novel functional properties. J Biol Chem (2000) 275(34):26128-26135.
51. 1 receptors in stably cotransfected fibroblast cells. J Biol Chem (1998) 273(8):4718-4724.
52. Patel RC, Kumar U, Lamb DC, Eid JS, Rocheville M, Grant M, Rani A, Hazlett T, Patel SC, Gratton E, Patel YC: Ligand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells. Proc Natl Acad Sci USA (2002) 99(5):3294-3299.
53. Rocheville M, Lange DC, Kumar U, Patel SC, Patel RC, Patel YC: Receptors for dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity. Science (2000) 288(5463):154-157.
54. 2 receptor co-activation generates a novel phospholipase C-mediated calcium signal. J Biol Chem (2004) 279(34):35671-35678.
55. 1D-adrenergic receptors. J Pharmacol Exp Ther (2005) 313(1):16-23.
56. 3-adrenergic receptors generates a β-adrenergic signaling unit with distinct functional properties. J Biol Chem (2004) 279(27):28756-28765.
57. Visiers I, Ballesteros JA, Weinstein H: Three-dimensional representations of G protein-coupled receptor structures and mechanisms. Methods Enzymol (2002) 343:329-371.
58. Filizola M, Visiers I, Skrabanek L, Campagne F, Weinstein H: Functional mechanisms of G protein-coupled receptors in a structural context. In: Molecular Neuropharmacology: Strategies and Methods. Schousboe A, Bräuner-Osborne H (Eds), Humana Press Inc, Totowa, NJ, USA (2003):235-266.
59. Filizola M, Weinstein H: The study of G protein-coupled receptor oligomerization with computational modeling and bioinformatics. FEBS J (2005) 272(12):2926-2938. Provides an update of the main approaches from bioinformatics, enhanced by computational molecular modeling, that have been used to predict likely interfaces of dimerization/oligomerization of GPCRs. The results of such predictions are compared with data for rhodopsin-like GPCRs.
60. 2A receptor by disruption of the ionic lock of the arginine cage. Intl J Quantum Chem (2002) 88(1):65-75.
61. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, LeTrong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M et al. Crystal structure of rhodopsin: A G protein-coupled receptor. Science (2000) 289(5480):739-745.